329 completed, 16 recruiting, 16 unknown, 10 terminated. 127 Phase 3, 106 Phase 2, 53 Phase 4, 47 Not applicable, 35 Phase 1.
Follow Rhinitis, Allergic, Seasonal: new trials by email Literature Review of Rhinitis, Allergic, Seasonal trials Research Report on Rhinitis, Allergic, Seasonal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating Nasal and Ocular Immune Response to Conjunctival Allergen Exposure Standardized Allergen Extract, Timothy Grass (Phleum pratense) - Allergic Rhinoconjunctivitis | Recruiting | Dr. Anne Ellis | 12 | 2026-09-01 | 2026-10-01 | |
| Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis PL-14 Allergy Blocker, Ayr® Saline Nasal Mist - Seasonal Allergic Rhinitis (SAR), Allergic Rhinitis | Not applicable | Recruiting | Polyrizon Ltd. | 120 | 2026-09-01 | 2026-09-30 |
| Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis Rupatifen Fumarate Capsules, Rupatadine Fumarate Tablets, Rupatifen Fumarate Capsules Placebo - Seasonal Allergic Rhinitis | Phase 3 | Recruiting | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. | 550 | 2026-08-18 | 2026-09-09 |
| Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis Stapokibart, Placebo - Seasonal Allergic Rhinitis (SAR) | Phase 3 | Recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 136 | 2026-08-13 | 2026-09-03 |
| A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis SHR-1819 Injection, SHR-1819 Injection Placebo - Seasonal Allergic Rhinitis | Phase 3 | Active not recruiting | Guangdong Hengrui Pharmaceutical Co., Ltd | 220 | 2026-08-11 | 2026-10-22 |
| Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis ITI-9001, Placebo - Allergen Immunotherapy | Phase 1 | Recruiting | Immunomic Therapeutics, Inc. | 45 | 2026-06-20 | 2026-09-25 |
| Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) Stapokibart injection - Seasonal Allergic Rhinitis (SAR) | Phase 2 | Not yet recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 15 | 2026-06-01 | 2026-06-01 |
| Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis TQH2722 injection - Seasonal Allergic Rhinitis | Phase 2 | Recruiting | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 300 | 2026-03-19 | 2026-03-27 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis AK139, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Not yet recruiting | Akeso | 111 | 2026-03-02 | 2026-02-27 |
| Identification of B Regulatory Cells by Flow Cytometry Venepuncture, Allergen Specific Immunotherapy - Pollen Allergy, Venom Allergy | Recruiting | Hull University Teaching Hospitals NHS Trust | 80 | 2026-01-21 | 2026-09-17 | |
| A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure ALDP001 Nasal Spray, Placebo Nasal spray - Seasonal Allergic Rhinitis (SAR) | Phase 2 | Recruiting | Alixer Nexgen Therapeutics Limited | 164 | 2025-10-17 | 2025-10-22 |
| A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. GR1802 injection, Placebo - Allergic Rhinitis, Seasonal | Phase 3 | Not yet recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 144 | 2025-09-25 | 2025-09-30 |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis PG-011 nasal spray 0.6%(twice daily), Placebo - Seasonal Allergic Rhinitis, SAR | Phase 3 | Not yet recruiting | Prime Gene Therapeutics Co., Ltd. | 600 | 2025-09-15 | 2025-08-28 |
| Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study Observational - Allergic Asthma, Thunderstorm Asthma | Not applicable | Recruiting | University of Melbourne | 530 | 2025-08-27 | 2026-05-06 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis GR1802 injection, Placebo - Allergic Rhinitis, Seasonal | Phase 3 | Recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2025-08-15 | 2025-09-04 |
| A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis SHR-1819 Injection, SHR-1819 Injection Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Guangdong Hengrui Pharmaceutical Co., Ltd | 108 | 2025-08-06 | 2026-08-27 |
| Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis TQC2938 injection, TQC2938 Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 136 | 2025-07-31 | 2026-02-10 |
| Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis Placebo, MG-K10 Humanized Monoclonal Antibody Injection - Seasonal Allergic Rhinitis | Phase 2 / Phase 3 | Recruiting | Shanghai Mabgeek Biotech.Co.Ltd | 160 | 2025-03-20 | 2025-04-18 |
| A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis Pumecitinib Nasal Spray 0.3%, Pumecitinib Nasal Spray 0.6%, Placebo (twice daily) - Seasonal Allergic Rhinitis | Phase 2 | Completed | Prime Gene Therapeutics Co., Ltd. | 179 | 2025-03-12 | 2026-09-09 |
| Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis TQH2722 injection, TQH2722 Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 169 | 2025-03-10 | 2025-08-12 |
Showing 20 of 384. Sign in to see all of them.
Rhinitis, Allergic (80) · Hypersensitivity (51) · Rhinitis, Allergic, Perennial (32) · Rhinitis (30) · Asthma (20) · Conjunctivitis, Allergic (14) · Sneezing (10) · Nasal Obstruction (9) · Rhinorrhea (8) · Dermatitis, Atopic (4) · Food Hypersensitivity (4) · Pruritus (4) · Chronic Urticaria (3) · Respiratory Sounds (3)
Hypersensitivity, Immediate (384) · Nose Diseases (384) · Otorhinolaryngologic Diseases (384) · Respiratory Hypersensitivity (383) · Immune System Diseases (382) · Respiratory Tract Diseases (382) · Rhinitis (354) · Hypersensitivity (333) · Rhinitis, Allergic (304) · Infections (36) · Respiratory Tract Infections (33) · Pathological Conditions, Signs and Symptoms (22) · Bronchial Diseases (20) · Lung Diseases (20) · Lung Diseases, Obstructive (20)
azelastine (24) · Fluticasone (22) · Mometasone Furoate (20) · Cetirizine (19) · desloratadine (17) · montelukast (13) · Loratadine (11) · fexofenadine (11) · levocetirizine (10) · bilastine (9) · ciclesonide (9) · fluticasone furoate (9) · Beclomethasone (8) · Nasal Sprays (7) · Pseudoephedrine (7)
Organon and Co (37) · GlaxoSmithKline (31) · AstraZeneca (14) · Meda Pharmaceuticals (10) · Fraunhofer-Institute of Toxicology and Experimental Medicine (9) · UCB Pharma (9) · Faes Farma, S.A. (7) · University of Chicago (7) · Imperial College London (6) · Merck Sharp & Dohme LLC (6) · Stallergenes Greer (6) · Allergy Therapeutics (5) · BioTech Tools S.A. (5) · Laboratorios Leti, S.L. (5) · Magna Pharmaceuticals, Inc. (5)
United States (107) · Germany (37) · Canada (31) · China (27) · United Kingdom (18) · Austria (14) · Poland (12) · Belgium (10) · Denmark (10) · Spain (10) · Netherlands (9) · Sweden (7) · Italy (6) · Russia (6) · Finland (5)
Lewis M Fredane, MD (6) · Luo Zhang (6) · Stephen J Pollard, MD (5) · Robert M Naclerio, MD (4) · Sudeesh Tantry, PhD (4) · Tim McNamara, PharmD (3) · Angelika Sager, Dr. med. (2) · Anish Bhatnagar, MD (2) · Anne K Ellis, MD (2)
PMID 19001265, PMID 20819318, PMID 28392807, PMID 32679209, PMID 33099797, PMID 40626378, PMID 11345288, PMID 12086367, PMID 12100048, PMID 14619332, PMID 15049402, PMID 15051938, PMID 15679739, PMID 16387596, PMID 16890769, PMID 16913264, PMID 17021320, PMID 17578494, PMID 17620075, PMID 17620076, PMID 17631952, PMID 17883732, PMID 18155284, PMID 18374405, PMID 18426137, PMID 18595980, PMID 18681494, PMID 18814452, PMID 18946234, PMID 19127072, PMID 19132976, PMID 19230461, PMID 19428097, PMID 19438584, PMID 19441605, PMID 19449366, PMID 19504468, PMID 19549427, PMID 19624554, PMID 19647862, PMID 19680119, PMID 19748656, PMID 19788025, PMID 19943178, PMID 20152080, PMID 20350147, PMID 20377116, PMID 20412135, PMID 20434199, PMID 20674829
2018 (3), 2005 (2), 2009 (2), 2015 (2), 2023 (2), 2004 (1), 2014 (1), 2017 (1), 2019 (1)